EGFR and non-small cell lung carcinoma: The tumors with the greatest number of patients (n > 6): NSCLC, nasopharyngeal, colorectal, renal and liver carcinoma showed co-expression (EGFR/NeuGcGM3) in more than 50 % of their tumoral cells.